These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15134444)
1. Semisynthesis of phosphovariants of Smad2 reveals a substrate preference of the activated T beta RI kinase. Ottesen JJ; Huse M; Sekedat MD; Muir TW Biochemistry; 2004 May; 43(19):5698-706. PubMed ID: 15134444 [TBL] [Abstract][Full Text] [Related]
2. Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition. Peng SB; Yan L; Xia X; Watkins SA; Brooks HB; Beight D; Herron DK; Jones ML; Lampe JW; McMillen WT; Mort N; Sawyer JS; Yingling JM Biochemistry; 2005 Feb; 44(7):2293-304. PubMed ID: 15709742 [TBL] [Abstract][Full Text] [Related]
3. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis. Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872 [TBL] [Abstract][Full Text] [Related]
4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
5. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture. Alvarez J; Serra R Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903 [TBL] [Abstract][Full Text] [Related]
6. Acceleration of Smad2 and Smad3 phosphorylation via c-Jun NH(2)-terminal kinase during human colorectal carcinogenesis. Yamagata H; Matsuzaki K; Mori S; Yoshida K; Tahashi Y; Furukawa F; Sekimoto G; Watanabe T; Uemura Y; Sakaida N; Yoshioka K; Kamiyama Y; Seki T; Okazaki K Cancer Res; 2005 Jan; 65(1):157-65. PubMed ID: 15665291 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. Souchelnytskyi S; Tamaki K; Engström U; Wernstedt C; ten Dijke P; Heldin CH J Biol Chem; 1997 Oct; 272(44):28107-15. PubMed ID: 9346966 [TBL] [Abstract][Full Text] [Related]
8. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species. Li WQ; Qureshi HY; Liacini A; Dehnade F; Zafarullah M Free Radic Biol Med; 2004 Jul; 37(2):196-207. PubMed ID: 15203191 [TBL] [Abstract][Full Text] [Related]
11. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Yang J; Dai C; Liu Y J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870 [TBL] [Abstract][Full Text] [Related]
12. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous triggering of protein activity and fluorescence. Pellois JP; Hahn ME; Muir TW J Am Chem Soc; 2004 Jun; 126(23):7170-1. PubMed ID: 15186142 [TBL] [Abstract][Full Text] [Related]
14. Analysis of Smad nucleocytoplasmic shuttling in living cells. Nicolás FJ; De Bosscher K; Schmierer B; Hill CS J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432 [TBL] [Abstract][Full Text] [Related]
15. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes. Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Saura M; Zaragoza C; Herranz B; Griera M; Diez-Marqués L; Rodriguez-Puyol D; Rodriguez-Puyol M Circ Res; 2005 Nov; 97(11):1115-23. PubMed ID: 16239590 [TBL] [Abstract][Full Text] [Related]
17. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Imamichi Y; Waidmann O; Hein R; Eleftheriou P; Giehl K; Menke A Biol Chem; 2005 Mar; 386(3):225-36. PubMed ID: 15843168 [TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Schmierer B; Hill CS Mol Cell Biol; 2005 Nov; 25(22):9845-58. PubMed ID: 16260601 [TBL] [Abstract][Full Text] [Related]
19. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells. Gajewska M; Motyl T Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067 [TBL] [Abstract][Full Text] [Related]
20. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Javelaud D; Mauviel A Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]